Indication

Hypocellular Marrow

1 clinical trial

1 product

Clinical trial
Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia
Status: Recruiting, Estimated PCD: 2029-05-21
Product
Emapalumab